Image

The Incidence of Complete Posterior Vitreous Degeneration After Phacoemulsification

The Incidence of Complete Posterior Vitreous Degeneration After Phacoemulsification

Recruiting
50 years and older
All
Phase N/A

Powered by AI

Overview

Intraocular surgery could induce vitreous degeneration and then abnormal posterior vitreous detachment (PVD) could occur including vitreoschisis and partial-thickness PVD. Vitreomacular interface (VMI) abnormalities such as epimacular membrane were observed following many intraocular surgeries. The incidence of peripheral break and epimacular membrane (EMM) after pneumatic retinopexy were 11.7% and 4-11%, respectively. Although multiple intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections induced PVD of 5.6%, but peripheral break was reported as only 0.67%. The incidence of rhegmatogenous retinal detachment (RRD) after phacoemulsification is gradually increased with time. The accumulative risk of RRD was increased from 0.27% at 1 year to 1.27% at 20 years after phacoemulsification.

Description

The most common intraocular surgery is cataract surgery. From the literature review, many methods were used to detect the PVD after phacoemulsification. The former studies used indirect ophthalmoscopy and ocular ultrasound for diagnosis of PVD. The later studies used the optical coherence tomography (OCT) for PVD detection. The OCT device had higher effectiveness in evaluation of the posterior segment, and then it can detect post-phacoemulsification PVD more and early than previous studies. Ivastinovic et al demonstrated 59.2% of patients had PVD at 1 month after phacoemulsification, and increased up to 71.4% at 3 months.

Tsukahara et al introduced wide-field OCT-based PVD classification. The advance OCT device will be useful in detection of abnormal PVD and it's sequelae. If the risk factors of post-phacoemulsification PVD were explored, the prevention of abnormal PVD and VMI disorders could be done.

Eligibility

Inclusion Criteria:

  • Cataract patients who was scheduled for phacoemulsification
  • Age >50 years
  • No complete PVD was detected by OCT
  • Can be taken the wide-field OCT images
  • Written informed consent

Exclusion Criteria:

  • Secondary cataract)
  • History of ocular trauma or head trauma
  • Systemic diseases that can cause the intraocular problems such as connective tissue disease
  • History of other ocular diseases such as glaucoma, uveitis and vitreoretinal disorders
  • History of intraocular laser treatment
  • History of intraocular surgery such as intravitreal drug injection

Withdrawal Criteria:

  • Intraoperative complications such as posterior capsular rupture and zonule dialysis
  • Postoperative complications such as vitreous hemorrhage and postoperative endophthalmitis
  • Undergo the intraocular surgery during the follow-up period
  • Receiving the intraocular laser treatment during the follow-up period such as laser capsulotomy and panretinal photocoagulation
  • Having the ocular trauma or head trauma during the follow-up period

Study details
    Posterior Vitreous Detachment

NCT04727398

Khon Kaen University

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.